New pill tested to help kids focus in school
NCT ID NCT05286762
Summary
This study tested a new once-daily pill called CTx-1301 for treating ADHD in children and teenagers aged 6 to 17. Over 100 participants were randomly assigned to receive either the active drug or a placebo (a pill with no medicine) for about 5 weeks to see if it safely improved ADHD symptoms. The main goal was to measure changes in symptoms like inattention and hyperactivity using standard rating scales.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Access Clinical Trials Inc.
Nashville, Tennessee, 37203, United States
-
Atlanta Center for Medical Research
Atlanta, Georgia, 30331, United States
-
BioBehavioral Research of Austin
Austin, Texas, 78759, United States
-
Center for Psychiatry and Behavioral Medicine. Inc.
Las Vegas, Nevada, 89128, United States
-
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, 32256, United States
-
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, 32801, United States
-
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, 38119, United States
-
Clinical Research Partners LLC
Petersburg, Virginia, 23805, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
-
Coastal Pediatric Associates
Charleston, South Carolina, 29414, United States
-
Dayton Clinical Research
Dayton, Ohio, 45409, United States
-
Family Psychiatry of The Woodlands
Woodland, Texas, 77381, United States
-
FutureSearch Trials
Dallas, Texas, 75231, United States
-
Gadolin Research
Beaumont, Texas, 77702, United States
-
Hassman Research Institute
Berlin, New Jersey, 08009, United States
-
Houston Clinical Trials
Bellaire, Texas, 77401, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Meridien Research
Maitland, Florida, 32751, United States
-
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan, 48302, United States
-
Red Oak Psychiatry Associates, PA
Houston, Texas, 77090, United States
-
SP Research PLLC
Oklahoma City, Oklahoma, 73112, United States
-
Sisu Bhr, Llc
Springfield, Massachusetts, 01103, United States
-
St Charles Psychiatric Associates & Midwest Research Group
Saint Charles, Missouri, 63304, United States
-
Summit Research Network, LLC
Portland, Oregon, 97210, United States
Conditions
Explore the condition pages connected to this study.